A Mesh-Free Solution to Treat Pelvic Organ Prolapse
March 29, 2021
The power of dCELL Technology: Innovative approach to tissue regeneration
Did you know that approximately 300,000 women in the U.S. undergo surgical procedures for pelvic organ prolapse (POP) each year — and the prevalence increases with age? Many suffer in silence because of the perceived stigma associated with the condition, but treatment innovations are now available. ARMS Medical is providing innovative solutions for women’s pelvic health issues. Their pioneering technologies, including dCELL® Technology for pelvic floor surgery, may help women recover faster, and may lead to fewer complications, compared to older techniques.
Their innovative approach to pelvic floor surgery is based on the use of a next-generation tissue, DermaPure® and VNEW™, decellularized dermal allografts featuring patented dCELL® Technology which stimulate natural healing, minimize scarring, and are used to reinforce the repair of damaged tissue. DermaPure® and VNEW™ with dCELL® Technology have shown improved safety and efficacy in over 3,000 pelvic floor surgeries.
Bringing the best tips from the experts in Atlanta in business, beauty, wealth management, child healthcare, car shopping, and more. Each year, Atlanta’s Women’s Entrepreneurship Initiative selects 15 local female entrepreneurs for a 15-month business training program. We meet women who have grown their companies, created jobs, and broke through the glass ceiling. With some […]
iMCD is the deadliest subtype of Castleman disease. Approximately one third of patients die within five years of diagnosis, and another third die within 10 years if not treated.
There are no effective treatment options for people with unresectable or metastatic chondrosarcoma despite many attempts by multiple pharmaceutical companies over the past few decades.